Men with prostate cancer are being given false hope by tests that underestimate the aggressiveness of their disease, a study suggests.
Researchers found that more than half of a group of men whose cancers were initially classified as slow-growing and confined turned out to have more dangerous tumours.
The findings, published in the British Journal Of Cancer, call into question the ability of experts to grade and stage prostate cancers on the basis of biopsy samples.
It also casts doubt on the "active surveillance" strategy of avoiding unnecessary radical treatment for patients with slow-growing prostate cancer.
Instead, these patients are often closely monitored but left alone until tests suggest their condition has worsened.
More top news
Thierry Henry's comical reaction to the sacking of Liverpool manager Brendan Rodgers sent Twitter into overdrive.
A daughter kissed her "dead" mother goodbye - only to find out that the hospital had made a mistake and her mother was still alive.
A nurse trying to identify a badly wounded hit-and-run victim suffered heartbreak when she discovered it was her own brother.